ISRCTN77591825已完成1 期
A drug-dr interaction study of the effect of BIIB122/DNL151 on midazolam pharmacokinetics in healthy participants
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 14
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Healthy female participants of non-childbearing potential or healthy male participants between 18 and 50 years of age, inclusive
- •2. Body mass index (BMI) between 18.5 and 31.0 kg/m² and a body weight of at least 50 kg
排除标准
- •1. Take any concomitant medication at the time of screening or during the study, unless deemed acceptable by the investigator (or designee) and Sponsor
- •2. Any history of hepatic, pulmonary, and/or renal disease
- •3. History of serious adverse reaction or serious hypersensitivity to any drug
- •4. History of allergy to any component of the study intervention
- •5. Have any surgical or medical condition affecting drug absorption (eg, gastrectomy)
研究者
相似试验
已完成
不适用
A Phase 1 Drug-Drug Interaction Study Between Brigatinib and the CYP3A Substrate Midazolam in Patients With ALK-Positive or ROS1-Positive Solid Tumorssolid tumortumor that develops in an organ10027656NL-OMON48899ARIAD wholly owned subsidiary of Takeda Pharmaceutical Company Limited4
已完成
4 期
Study of the interaction between Complementary and Alternative Medicine and standard anti-cancer therapy in women with breast cancerCancer - BreastAlternative and Complementary Medicine - Other alternative and complementary medicineBreast cancerACTRN12615000673549Gregory Peterson20
已完成
1 期
Clinical pharmacology study of BBI608o indicationJPRN-jRCT2080225351Sumitomo Dainippon Pharma. Co,.Ltd.70
招募中
不适用
Prospective Clinical Drug-Drug Interaction study between Rifampicin and Fusidic AcidMedication interactionInfection - Other infectious diseasesACTRN12619001247167St Vincent's Hospital Melbourne12
尚未招募
2 期
Add On Effect Of Basti In Non-Alcoholic Fatty Liver Disease.CTRI/2024/03/064543All India Institute Of Ayurveda